Bruce K Crowther's most recent trade in Methode Electronics, Inc. was a trade of 14,170 Common Stock done at an average price of $9.9 . Disclosure was reported to the exchange on June 13, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Methode Electronics, Inc. | Bruce K. Crowther | Director | Grant, award, or other acquisition of securities at price $ 9.88 per share. | 13 Jun 2024 | 14,170 | 32,111 (0%) | 0% | 9.9 | 140,000 | Common Stock |
| Neogenomics Inc. | Bruce K. Crowther | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 11,336 | 11,336 | - | - | Restricted Stock Unit | |
| Neogenomics Inc. | Bruce K. Crowther | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 8,353 | 8,353 | - | - | Stock Option (Right to Buy) | |
| Methode Electronics, Inc. | Bruce K. Crowther | Director | Grant, award, or other acquisition of securities at price $ 33.33 per share. | 05 Jul 2023 | 4,201 | 17,941 (0%) | 0% | 33.3 | 140,019 | Common Stock |
| Wintrust Financial Corp. | Bruce K. Crowther | Director | Grant, award, or other acquisition of securities at price $ 81.55 per share. | 31 Dec 2022 | 686 | 44,545 (0%) | 0% | 81.5 | 55,943 | Common Stock |
| Wintrust Financial Corp. | Bruce K. Crowther | Director | Grant, award, or other acquisition of securities at price $ 80.15 per share. | 30 Sep 2022 | 695 | 43,859 (0%) | 0% | 80.1 | 55,704 | Common Stock |
| Methode Electronics, Inc. | Bruce K. Crowther | Director | Grant, award, or other acquisition of securities at price $ 36.04 per share. | 07 Jul 2022 | 3,885 | 13,740 (0%) | 0% | 36.0 | 140,015 | Common Stock |
| Wintrust Financial Corp. | Bruce K. Crowther | Director | Grant, award, or other acquisition of securities at price $ 92.93 per share. | 30 Jun 2022 | 598 | 43,164 (0%) | 0% | 92.9 | 55,572 | Common Stock |
| Neogenomics Inc. | Bruce K. Crowther | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 15,556 | 65,120 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | Bruce K. Crowther | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 13,882 | 13,882 | - | - | Stock Option (Right to Buy) | |
| Wintrust Financial Corp. | Bruce K. Crowther | Director | Grant, award, or other acquisition of securities at price $ 90.82 per share. | 31 Mar 2022 | 609 | 42,566 (0%) | 0% | 90.8 | 55,309 | Common Stock |
| Wintrust Financial Corp. | Bruce K. Crowther | Director | Grant, award, or other acquisition of securities at price $ 75.63 per share. | 30 Sep 2021 | 627 | 41,364 (0%) | 0% | 75.6 | 47,420 | Common Stock |
| Methode Electronics, Inc. | Bruce K. Crowther | Director | Grant, award, or other acquisition of securities at price $ 47.39 per share. | 07 Jul 2021 | 2,955 | 9,855 (0%) | 0% | 47.4 | 140,037 | Common Stock |
| Wintrust Financial Corp. | Bruce K. Crowther | Director | Grant, award, or other acquisition of securities at price $ 75.80 per share. | 30 Jun 2021 | 623 | 40,737 (0%) | 0% | 75.8 | 47,223 | Common Stock |
| Neogenomics Inc. | Bruce K. Crowther | Director | Sale of securities on an exchange or to another person at price $ 41.46 per share. | 08 Jun 2021 | 20,734 | 49,564 (0%) | 0% | 41.5 | 859,632 | Common Stock |
| Neogenomics Inc. | Bruce K. Crowther | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2021 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Neogenomics Inc. | Bruce K. Crowther | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 08 Jun 2021 | 10,000 | 59,564 (0%) | 0% | 7.3 | 72,700 | Common Stock |
| Neogenomics Inc. | Bruce K. Crowther | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.52 per share. | 08 Jun 2021 | 4,269 | 66,850 (0%) | 0% | 22.5 | 96,138 | Common Stock |
| Neogenomics Inc. | Bruce K. Crowther | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2021 | 4,269 | 0 | - | - | Stock Option (Right to Buy) | |
| Neogenomics Inc. | Bruce K. Crowther | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.54 per share. | 08 Jun 2021 | 3,448 | 70,298 (0%) | 0% | 28.5 | 98,406 | Common Stock |
| Neogenomics Inc. | Bruce K. Crowther | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2021 | 3,448 | 0 | - | - | Stock Option (Right to Buy) | |
| Neogenomics Inc. | Bruce K. Crowther | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.60 per share. | 08 Jun 2021 | 3,017 | 62,581 (0%) | 0% | 11.6 | 34,997 | Common Stock |
| Neogenomics Inc. | Bruce K. Crowther | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2021 | 3,017 | 0 | - | - | Stock Option (Right to Buy) | |
| Wintrust Financial Corp. | Bruce K. Crowther | Director | Grant, award, or other acquisition of securities at price $ 61.09 per share. | 31 Mar 2021 | 770 | 40,114 (0%) | 0% | 61.1 | 47,039 | Common Stock |
| Wintrust Financial Corp. | Bruce K. Crowther | Director | Grant, award, or other acquisition of securities at price $ 43.62 per share. | 30 Sep 2020 | 1,036 | 38,207 (0%) | 0% | 43.6 | 45,190 | Common Stock |
| Neogenomics Inc. | Bruce K. Crowther | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.11 per share. | 22 Sep 2020 | 8,333 | 54,816 (0%) | 0% | 9.1 | 75,914 | Common Stock |
| Neogenomics Inc. | Bruce K. Crowther | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Sep 2020 | 8,333 | 0 | - | - | Stock Option (Right to Buy) | |
| Neogenomics Inc. | Bruce K. Crowther | Director | Sale of securities on an exchange or to another person at price $ 35.01 per share. | 22 Sep 2020 | 8,333 | 46,483 (0%) | 0% | 35.0 | 291,738 | Common Stock |
| Neogenomics Inc. | Bruce K. Crowther | Director | Sale of securities on an exchange or to another person at price $ 35.68 per share. | 22 Sep 2020 | 2,400 | 46,483 (0%) | 0% | 35.7 | 85,632 | Common Stock |